RIG-I ligand enhances the immunogenicity of recombinant H7 HA protein
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

RIG-I ligand enhances the immunogenicity of recombinant H7 HA protein
Filetype[PDF-960.70 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 513.89 KB]
    Personal Author:
    Belser, Jessica A.; Sun, Xiangjie; Creager, Hannah M.; Johnson, Adam; Ridenour, Callie; Chen, Li-Mei; Tumpey, Terrence M.; Maines, Taronna R.;
    Published Date:
    December 10 2016
    Source:
    Virology. 502:13-19
    Description:
    H7 subtype influenza viruses have demonstrated an ocular tropism in humans, causing conjunctivitis and not respiratory symptoms in many infected individuals. However, the molecular determinants which confer ocular tropism are still poorly understood....
    File Type:
    Filetype[PDF - 513.89 KB]
  2. Filetype[PDF - 349.97 KB]
    Personal Author:
    Steitz, Julia; Barlow, Peter G.; Hossain, Jaber; Kim, Eun; Okada, Kaori; Kenniston, Tom; Rea, Sheri; Donis, Ruben O.; Gambotto, Andrea;
    Published Date:
    May 05 2010
    Source:
    PLoS One. 5(5).
    Description:
    BackgroundIn 2009 a new pandemic disease appeared and spread globally. The recent emergence of the pandemic influenza virus H1N1 first isolated in Mexico and USA raised concerns about vaccine availability. We here report our development of an adenovi...
    File Type:
    Filetype[PDF - 349.97 KB]
  3. Filetype[PDF - 3.28 MB]
    Personal Author:
    Marjuki, Henju; Mishin, Vasiliy P.; Chai, Ning; Tan, Man-Wah; Newton, Elizabeth M.; Tegeris, John; Erlandson, Karl; Willis, Melissa; Jones, Joyce; Davis, Todd; Stevens, James; Gubareva, Larisa V.;
    Published Date:
    November 14 2016
    Source:
    J Virol. 2016; 90(23):10446-10458
    Description:
    The pandemic threat posed by emerging zoonotic influenza A viruses necessitates development of antiviral agents effective against various antigenic subtypes. Human monoclonal antibody (hMAb) targeting the hemagglutinin (HA) stalk offers a promising a...
    File Type:
    Filetype[PDF - 3.28 MB]
  4. Filetype[PDF - 103.31 KB]
    Personal Author:
    Thomas, Paul G.; Keating, Rachael; Hulse-Post, Diane J.; Doherty, Peter C.;
    Published Date:
    Jan 2006
    Source:
    Emerg Infect Dis. 12(1):48-54.
    Description:
    Current vaccine strategies against influenza focus on generating robust antibody responses. Because of the high degree of antigenic drift among circulating influenza strains over the course of a year, vaccine strains must be reformulated specifically...
    File Type:
    Filetype[PDF - 103.31 KB]
  5. Filetype[PDF - 1.04 MB]
    Personal Author:
    Marjuki, Henju; Mishin, Vasiliy P.; Chesnokov, Anton P.; Jones, Joyce; De La Cruz, Juan A.; Sleeman, Katrina; Tamura, Daisuke; Nguyen, Ha T.; Wu, Ho-Sheng; Chang, Feng-Yee; Liu, Ming-Tsan; Fry, Alicia M.; Cox, Nancy J.; Villanueva, Julie M.; Davis, Charles T.; Gubareva, Larisa V.;
    Published Date:
    August 14 2014
    Source:
    J Infect Dis. 211(2):249-257
    Description:
    Background.Patients contracting influenza A(H7N9) infection often developed severe disease causing respiratory failure. Neuraminidase (NA) inhibitors (NAIs) are the primary option for treatment, but information on drugresistance markers for influenza...
    File Type:
    Filetype[PDF - 1.04 MB]